CHCLPharmaceuticals
Cian Healthcare Ltd — Cash Flow Statement
₹73.03
+0.00%
Cian Healthcare Ltd Cash Flow Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Free Cash Flow | 10.79 Cr | 3.52 Cr | -8.74 Cr | 4.46 Cr |
| Repayment Of Debt | -1.89 Cr | -8.75 Cr | — | -8.20 Cr |
| Capital Expenditure | -0.98 Cr | -1.32 Cr | -17.32 Cr | -1.47 Cr |
| End Cash Position | 1.19 Cr | 1.33 Cr | 1.34 Cr | 2.32 Cr |
| Beginning Cash Position | 1.33 Cr | 1.34 Cr | 2.32 Cr | 3.45 Cr |
| Changes In Cash | -0.14 Cr | -0.01 Cr | -0.98 Cr | -1.13 Cr |
| Financing Cash Flow | -10.44 Cr | -7.41 Cr | -10.96 Cr | -9.78 Cr |
| Net Other Financing Charges | 1000.00 | — | — | — |
| Interest Paid Cff | -5.32 Cr | -5.17 Cr | -6.05 Cr | -7.35 Cr |
| Net Issuance Payments Of Debt | -5.12 Cr | -2.23 Cr | -7.68 Cr | -2.43 Cr |
| Net Short Term Debt Issuance | -3.24 Cr | 6.51 Cr | -8.17 Cr | 5.77 Cr |
| Net Long Term Debt Issuance | -1.89 Cr | -8.75 Cr | 0.49 Cr | -8.20 Cr |
| Long Term Debt Payments | -1.89 Cr | -8.75 Cr | — | -8.20 Cr |
| Investing Cash Flow | -1.46 Cr | 2.55 Cr | 1.40 Cr | 2.71 Cr |
| Interest Received Cfi | 0.10 Cr | 0.14 Cr | 0.16 Cr | 0.19 Cr |
| Net Investment Purchase And Sale | -0.58 Cr | 3.74 Cr | 5.62 Cr | 3.99 Cr |
| Net PPE Purchase And Sale | -0.98 Cr | -1.32 Cr | -4.38 Cr | -1.47 Cr |
| Purchase Of PPE | -0.98 Cr | -1.32 Cr | -17.32 Cr | -1.47 Cr |
| Operating Cash Flow | 11.76 Cr | 4.84 Cr | 8.58 Cr | 5.93 Cr |
| Change In Working Capital | 0.84 Cr | -7.28 Cr | 4.45 Cr | -4.95 Cr |
| Change In Other Current Liabilities | 1.43 Cr | 3.19 Cr | 4.96 Cr | -1.88 Cr |
| Change In Other Current Assets | -6.21 Cr | -5.62 Cr | 1.29 Cr | 2.11 Cr |
| Change In Payable | 4.17 Cr | -8.40 Cr | 14.92 Cr | 4.33 Cr |
| Change In Inventory | -4.28 Cr | 2.73 Cr | -8.65 Cr | -11.01 Cr |
| Change In Receivables | 5.75 Cr | 0.49 Cr | -7.82 Cr | 1.09 Cr |
| Other Non Cash Items | 5.22 Cr | 5.03 Cr | 5.89 Cr | 7.16 Cr |
| Deferred Tax | -0.02 Cr | -0.37 Cr | -0.47 Cr | 0.22 Cr |
| Depreciation And Amortization | 5.47 Cr | 5.43 Cr | 4.24 Cr | 3.45 Cr |
| Depreciation | 5.47 Cr | 5.43 Cr | 4.24 Cr | 3.45 Cr |
| Net Income From Continuing Operations | 0.25 Cr | 2.03 Cr | -5.53 Cr | 0.05 Cr |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | 1000.00 | -1000.00 |
| Net Other Investing Changes | — | 1000.00 | — | -1000.00 |
| Net Business Purchase And Sale | — | 0.00 | 0.00 | — |
| Purchase Of Business | — | 0.00 | 0.00 | — |
| Gain Loss On Sale Of PPE | — | 0.00 | 0.00 | — |
| Issuance Of Debt | — | — | 0.49 Cr | — |
| Issuance Of Capital Stock | — | — | 2.78 Cr | — |
| Net Common Stock Issuance | — | — | 2.78 Cr | — |
| Common Stock Issuance | — | — | 2.78 Cr | — |
| Long Term Debt Issuance | — | — | 0.49 Cr | — |
| Sale Of PPE | — | — | 12.94 Cr | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Cian Healthcare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.